Over the course of 35 days, the results of the tumor volume and weight analysis revealed that the ACADS-silenced HCCLM3 cells generated larger subcutaneous xenograft tumors in nude mice as compared to the cells transfected with control shRNA (P<0.05; Figure 4B–4D). The gene discussed is ACADS; the disease is neoplasm.